Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D001779:Blood Coagulation Factors; D002417:Cattle; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents; D006801:Humans; D010958:Plasminogen / Q000032:analysis*; D013552:Swine; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D000614:Aminocaproates; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator